Corporate Development     

Published: August 15, 2024
Updated: August 15, 2024

Evexia Lifecare Ltd.

Board of directors approves conversion of FCCBs

Evexia Lifecare Ltd. (BSE: 524444), engaged in trading of chemicals, manufacturing of intermediates, agricultural produce and various other products of consumer goods, has announced that the members of the company had approved the issue of the foreign currency convertible bonds in the annual general meeting held on July 9, 2022. The board has considered and approved conversion of 25 bonds into equity shares as per the terms and conditions of the issue of FCCB. Recently, the Board of Directors at its meeting held on June 17, 2024 had also considered and approved conversion of 75 bonds into equity shares as per the terms and conditions of the issue of FCCB.

Earlier, Evexia Lifecare Ltd. Announced that it had incorporated a subsidiary company namely “EVEXIA LIFECARE AFRICA LIMITED (CIN: 14497377)”which is registered with the Registrar of Companies for England and Wales. The Registrar of Companies for England and Wales has issued a Certificate of Incorporation for the same. Evexia Lifecare Formed the New Subsidiary to Set Up Pathology Labs in Africa.

Evexia Lifecare Ltd. is engaged in trading of pharmaceuticals, chemicals, manufacturing of intermediates, agri cultural produce and various other products of consumer goods. It is mainly engaged in trading of pharma chemicals. The company in trading of various petrochemical downstream products, such as special oils, special chemicals, petroleum sulphates and solvents for industrial applications, such as rubber, leather, ink and paint industries. Its products include pharma intermediates, plastic granule, chemicals, and gold and diamond. The company focuses to expand its line of business in Web development, software development for overseas clients, trading in gold and entertainment segment.

The company is committed to delivering high-quality products and services to its customers. It aims to achieve customer satisfaction by providing cost-effective and timely solutions. The company has a team of experienced professionals who ensure that the products meet the highest standards of quality.

Evexia Lifecare Ltd is a company that values innovation and keeps up with the latest technologies and trends in the industry. It strives to provide its customers with the best solutions and services that meet their evolving needs. The company has a long-term vision of expanding its business globally and establishing itself as a leader in the industry.

September 30, 2024 - Second Issue

Industry Review

VOL XVI - 03
September 16-30, 2024

Formerly Fortune India Managing Editor Deven Malkan Assistant Editor A.K. Batha President Bhupendra Shah Circulation Executive Warren Sequeira Art Director Prakash S. Acharekar Graphic Designer Madhukar Thakur Investment Analysis CI Research Bureau Anvicon Research DD Research Bureau Manager (Special Projects) Bhagwan Bhosale Editorial Associates New Delhi Ranjana Arora Bureau Chief Kolkata Anirbahn Chawdhory Gujarat Pranav Brahmbhatt Bureau Cheif Mobile: 098251-49108 Bangalore Jaya Padmanabhan Bureau Chief Chennai S Gururajan Bureau Chief (Tamil Nadu) Ludhiana Ajitkumar Vijh Bhubaneshwar Braja Bandhu Behera

Want to Subscribe?


Lighter Vein

Popular Stories

E-Waste Dilemma Tackling E-Waste Via Reverse Logistics, By Vihaan Shah

A modern-day enigma and a ramification of humanity's never-ending advancements, e-waste refers to the scum con- cealed by the outward glow of ever-advancing technology.

Archives

About Us    Contact Us    Careers    Terms & Condition    Privacy Policy

Liability clause: The investment recommendations made here are based on the personal judgement of the authors concerned. We do not accept liability for any losses that might occur. All rights reserved. Reproduction in any manner, in whole or in part, in English or in any other language is prohibited.

Copyright © 1983-2024 Corporate India. All Rights Reserved.

www.corporateind.com | Cookie Policy | Disclaimer